Perspective Therapeutics (CATX) EBITDA Margin Growth (3y) (2013 - 2023)
Perspective Therapeutics (CATX) EBITDA Margin Growth (3y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.88 Bn | 197.28 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 126.34 Bn | 122.87 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.78 Bn | 110.56 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 74.35 Bn | 73.81 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.73 Bn | 47.47 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 35.36 Bn | 33.41 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.23 Bn | 22.91 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 244.00 |
| 10 | Perspective Therapeutics | 397.55 Mn | 397.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 27,520.00 |
| Sep 30, 2023 | -41,627.00 |
| Jun 30, 2023 | -59,809.00 |
| Mar 31, 2023 | -45,412.00 |
| Sep 30, 2022 | -7,171.00 |
| Jun 30, 2022 | -484.00 |
| Mar 31, 2022 | 1,316.00 |
| Dec 31, 2021 | 1,699.00 |
| Sep 30, 2021 | 849.00 |
| Jun 30, 2021 | 19,752.00 |
| Mar 31, 2021 | 5,566.00 |
| Dec 31, 2020 | 5,857.00 |
| Sep 30, 2020 | 9,821.00 |
| Jun 30, 2020 | 8,389.00 |
| Mar 31, 2020 | 8,932.00 |
| Dec 31, 2019 | 10,294.00 |
| Sep 30, 2019 | 10,959.00 |
| Jun 30, 2019 | 5,250.00 |
| Mar 31, 2019 | 5,032.00 |
| Dec 31, 2018 | 4,353.00 |